Clinical Trial Update: Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 clinical trial evaluating metformin as an adjunct to catheter ablation in atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Michigan | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED